GIP (Glucose-dependent insulinotropic polypeptide): This hormone helps lower blood sugar levels, particularly after eating, and contributes to improved fat metabolism helping the body process and store fat more efficiently
does not include medication costs | Medication costs: $99+/mo
The clinic describes reviewing health history, goals, treatment options, follow-up, and monitoring, with prescription treatment considered when appropriate
Given the relatively high level of gross Medicare Part D spending as of 2022 for the two semaglutide products combined, Ozempic and Rybelsus, its possible that Medicare could select this product for drug price negotiation as early as 2025, which would be just over seven years past its earliest FDA approval in late 2017
Liver function: Research has shown that semaglutide results in improved liver fat and scarring, and MASH (which stands for metabolic dysfunction-associated steatohepatitis) is an FDA-approved indication
Early studies look good right now